Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation

Hepatobiliary and Pancreatic Diseases International

Volumn 3, Issue 1, 2004, Pages 26-32

  Lu, Shi Chun ^a   Yan, Lu Nan ^a   Li, Bo ^a   Wen, Tian Fu ^a   Zhao, Ji Chun ^a   Cheng, Nan Sheng ^a   Liu, Chong ^a   Liu, Jun ^a   Wang, Xiao Bo ^a   Li, Xiao Dong ^a   Qin, Shan ^a   Zhao, Lian Shan ^a   Lei, Bin Jun ^a   Zhang, Xiu Hui ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Hepatitis B virus; Lamivudine; Liver cirrhosis; Liver transplantation

Indexed keywords

BIOTIN; DIGOXIN; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; STREPTAVIDIN; VIRUS DNA;

ADULT; ALLOGRAFT; ARTICLE; CHOLESTATIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ANALYSIS; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFECTION PREVENTION; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE INFECTION; PREOPERATIVE TREATMENT; PROPHYLAXIS; RADIOIMMUNOASSAY; RECIPIENT; REINFECTION; VIRUS REPLICATION;

ADULT; DNA, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREOPERATIVE CARE; RECURRENCE; REFERENCE VALUES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 10744220652     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Samuel D, Bismuth H, Marcellin P, Benhamou JP. Liver transplantation in the management of chronic viral hepatitis in: Zuckerman AJ, Thomas HC, eds. Viral Hepatitis, 2nd Edition. Churchill Livingstone: Harcourt Asia; 2001:237-244.
2. Lu SC, Yan LN, Li B, Ma YK, Liu C, Wen TF, et al. Dynamic alteration of HBV markers on active HBV replicative recipients after liver transplantation: a preliminary report. Hepatobiliary Pancreat Dis Int 2003;2:196-201.
3. Seehofer D, Rayes N, Neuman U, Neuhaus R, Nüller AR, Tullius SG, et al. Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation. Transplantation 2001;72:1381-1385.
4. Lee KW, Lee SK, Job JW, Kim SJ, Park JH, Chan SE, et al. Comparison of the efficacy in preventing of hepatitis B virus recurrence after liver transplantation between HBIG and lamivudine. Transplant Proc 2001;33:3643-3644.
5. Rosenau J, Tillmann HL, Hahr MJ, Trautwein C, Boeker KH, Nashan B, et al. Successful hepatitis B reinfection prophylaxis with lamivudine and hepatitis B immune globulin in patients with positive HBV-DNA at time of liver transplantation. Transplant Proc 2001;33:3637-3638.
6. Marzan A, Salizzoni M, Debernardi-Venon W, Smedile A, Franchello A, Ciancio A, et al. Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis. J Hepatol 2001;34:903-910.
7. Rosenau J, Bahr UJ, Tillmann HL, Trautwein C, Klempnauer J, Uanns MP, et al. Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation: possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection. J Hepatol 2001;34:895-902.
8. Fontana RJ, Hann HW, Wright T, Everson G, Baker A, Schiff ER, et al. Lamivudine compassionate use study group. A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation. Liver Transplant 2001;7: 504-510.
9. Han SH, Ofman J, Holt C, King K, Kunder G, Chen P, et al. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy. Liver Transplant 2000;6:741-748.
10. Seehofer D, Rayes N, Steinmuller T, Muller AR, Settmacher U, Neuhaus R, et al. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation. Liver Transplant 2001;7:976-982.
11. Segovia R, Sanchez-Fueyo A, Rimola A, Grande L, Bruguera M, Costa J, et al. Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation. Liver Transplant 2001;7:106-112.
12. Sanchez-Fueyo A, Rimola A, Grande L, Costa J, Mos A, Navasa M, et al. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation. Hepatology 2000; 31:496-500.
13. Steinmuller T, Seehofer D, Rayes N, Muller AR, Settmacher U, Jonas S, et al. Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease. Hepatology 2002;35:1528-1535.
14. Naoumov NV, Lopes AR, Burra P, Caccamo L, Temmolo RM, de Man RA, et al. Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation. J Hepatol 2001;34:888-894.
15. Ben-Ari Z, Mor E, Shapira Z, Tur-Kaspa R. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation. Liver Transplant 2001;7:113-117.
16. Perrillo RP, Wright T, Rakala J, Levy G, Schiff E, Gish R, et al. A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology 2001;33:424-432.
17. Macedo G, Maia JC, Gomes A, Beleza M, Teixeira AS, Ribeiro A. Lamivudine: a new strategy to suppress HBV replication in the pretransplant setting. Transplant Proc 2002; 32: 2642.
18. Yao FY, Terrault NA, Freise C, Maslow L, Bass NM. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort. Hepatology 2001;34:411-416.
19. Lo MC, Cheung ST, Lai CL, Liu CL, Ng IO, Yuan MF, et al. Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis. Ann Surg 2001;233:276-281.
20. Lai CL, Chien RN, Leung NWY, Chang TT, Guan R, Tai DI, et al. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998;339:61-68.
21. Lu SC, Yan LN, Li B, Liu Y, Wen TF, Zhao JC, et al. The analysis for the cause of anti-HBs emergence after liver transplantation for HB-related liver disease (In press).
22. Lu SC, Yan LN, Li B, Wen TF, Cheng NS, Zhao JC, et al. The etiology and management of early postoperative hyperbilirubinemia after liver transplantation. Chin J Organ Transplant 2003;24:73-75.
23. Zhu JP, Zhang TL, Li L, Yuan J, Song SB, Xiu DR, et al. Prevention and treatment of hepatitis B recurrence after liver transplantation. Hepatobiliary Pancreat Dis Int 2003; 2: 500-503.
24. Sponseller CA, Bacon BR, Di Bisceglie AM. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine. Liver Transplant 2000;6:715-720.
25. Kitay-Cohen Y, Ben-Ari Z, Tur-Kaspa R, Fainguelernt H, Lishner M. Extension of transplantation free time by lamivudine in patients with hepatitis B-induced decompensated cirrhosis. Transplantation 2000;69:2382-2383.
26. Barcena R, Dominguez-Antonaya M, Lopez-Sanroman A, Martinez-Turnes A, Urman J, del Campo S, et al. Lamivudine therapy of hepatitis B virus-related liver disease: cirrhosis, posttransplantation recurrence, and de novo infection. Transplant Proc 1999;31:2457-2458.
27. Ben-Ari Z, Pappo O, Zemel R, Mor E, Tur-Kaspa R. Association of lamivudine resistance in recurrent hepatitis B after liver transplantation with advanced hepatic fibrosis. Transplantation 1999;68:232-236.
28. So SK, Esquivel CO, Imperial JC, Garcia G, Monge H, Keeffe EB. Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis? J Gastroenterol Hepatol 1999;14:S48-52.